InnovAge Holding Corp. Repayments of Long-Term Debt
InnovAge Holding Corp. (INNV) reported Repayments of Long-Term Debt of $71.28 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-09-09
- InnovAge Holding Corp. repayments of long-term debt for the quarter ending 2026-06-30 was $10.00M, a 951.74% increase year-over-year.
- InnovAge Holding Corp. repayments of long-term debt for the quarter ending 2026-03-31 was $634.00K, a 33.26% decline year-over-year.
- InnovAge Holding Corp. repayments of long-term debt for the quarter ending 2025-12-31 was $634.00K, a 33.19% decline year-over-year.
- InnovAge Holding Corp. repayments of long-term debt for the quarter ending 2025-09-30 was $60.01M, a 6223.71% increase year-over-year.
- InnovAge Holding Corp. repayments of long-term debt for fiscal 2026 was $71.28M, a 1776.34% increase from fiscal 2025.
- InnovAge Holding Corp. repayments of long-term debt for fiscal 2025 was $3.80M, a 0.11% increase from fiscal 2024.
- InnovAge Holding Corp. repayments of long-term debt for fiscal 2024 was $3.79M, a 0.05% increase from fiscal 2023.
- InnovAge Holding Corp. repayments of long-term debt for fiscal 2023 was $3.79M, a 0.08% increase from fiscal 2022.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $10.64M derived: sum of 2 quarters · filed 2026-09-09 | $11.27M derived: sum of 3 quarters · filed 2026-09-09 | $71.28M 10-K · filed 2026-09-09 |
| 2026-03-31 | $634.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $1.27M derived: sum of 2 quarters · filed 2026-05-08 | $61.28M 10-Q · filed 2026-05-08 | $62.23M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $634.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $60.65M 10-Q · filed 2026-02-03 | $61.60M derived: sum of 3 quarters · filed 2026-09-09 | $62.55M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $60.01M 10-Q · filed 2025-11-04 | $60.96M derived: sum of 2 quarters · filed 2026-09-09 | $61.91M derived: sum of 3 quarters · filed 2026-09-09 | $62.86M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $951.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $1.90M derived: sum of 2 quarters · filed 2026-09-09 | $2.85M derived: sum of 3 quarters · filed 2026-09-09 | $3.80M 10-K · filed 2026-09-09 |
| 2025-03-31 | $950.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $1.90M derived: sum of 2 quarters · filed 2026-05-08 | $2.85M 10-Q · filed 2026-05-08 | $3.80M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $949.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $1.90M 10-Q · filed 2026-02-03 | $2.85M derived: sum of 3 quarters · filed 2026-02-03 | $3.80M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $949.00K 10-Q · filed 2025-11-04 | $1.90M derived: sum of 2 quarters · filed 2025-11-04 | $2.85M derived: sum of 3 quarters · filed 2025-11-04 | $3.80M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $1.90M derived: sum of 2 quarters · filed 2025-09-09 | $2.85M derived: sum of 3 quarters · filed 2025-09-09 | $3.79M 10-K · filed 2025-09-09 |
| 2024-03-31 | $949.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $1.90M derived: sum of 2 quarters · filed 2025-05-06 | $2.85M 10-Q · filed 2025-05-06 | $3.80M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $949.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $1.90M 10-Q · filed 2025-02-04 | $2.85M derived: sum of 3 quarters · filed 2025-02-04 | $3.79M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $948.00K 10-Q · filed 2024-11-05 | $1.90M derived: sum of 2 quarters · filed 2024-11-05 | $2.85M derived: sum of 3 quarters · filed 2024-11-05 | $3.79M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $950.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $1.90M derived: sum of 2 quarters · filed 2024-09-10 | $2.85M derived: sum of 3 quarters · filed 2024-09-10 | $3.79M 10-K · filed 2024-09-10 |
| 2023-03-31 | $948.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $1.90M derived: sum of 2 quarters · filed 2024-05-07 | $2.84M 10-Q · filed 2024-05-07 | $3.79M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $947.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $1.90M 10-Q · filed 2024-02-06 | $2.84M derived: sum of 3 quarters · filed 2024-02-06 | $3.79M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $948.00K 10-Q · filed 2023-11-07 | $1.90M derived: sum of 2 quarters · filed 2023-11-07 | $2.84M derived: sum of 3 quarters · filed 2023-11-07 | $3.79M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $1.90M derived: sum of 2 quarters · filed 2023-09-12 | $2.84M derived: sum of 3 quarters · filed 2023-09-12 | $3.79M 10-K · filed 2023-09-12 |
| 2022-03-31 | $947.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $1.89M derived: sum of 2 quarters · filed 2023-05-09 | $2.84M 10-Q · filed 2023-05-09 | $2.85M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $947.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $1.89M 10-Q · filed 2023-02-07 | $1.91M derived: sum of 3 quarters · filed 2023-02-07 | $301.16M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $947.00K 10-Q · filed 2022-11-08 | $958.00K derived: sum of 2 quarters · filed 2022-11-08 | $300.22M derived: sum of 3 quarters · filed 2022-11-08 | $300.98M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $299.27M derived: sum of 2 quarters · filed 2022-09-13 | $300.04M derived: sum of 3 quarters · filed 2022-09-13 | $512.66M 10-K · filed 2022-09-13 |
| 2021-03-31 | $299.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $300.02M derived: sum of 2 quarters · filed 2022-05-10 | $512.65M 10-Q · filed 2022-05-10 | $513.14M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $765.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | $213.39M 10-Q · filed 2022-02-09 | $213.88M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-09-30 | $212.63M 10-Q · filed 2021-11-09 | $213.11M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $1.93M 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $1.45M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |